EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Artesunate as an emerging anticancer modality: Insights and advances

Frantisek Petrlak, Vendula Jemelikova, Anna Hanzlikova, Terezie Slesingerova, Yazan Haddad, Igor Opsenica, Jamile Taniele-Silva, Miguel Angel Merlos Rodrigo

Pharmacological Research · 2026

DOI: 10.1016/j.phrs.2026.108317 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Pharmacological Research, 2026. Verfasst von Frantisek Petrlak und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry and Biochemistry, Mendel University in Brno, Zemedelska 1, Brno CZ-613 00, Czech Republic. Hauptthemen laut MEDLINE: Artesunate, Neoplasms, Antineoplastic Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 221 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Mendel University in Brno, National Council for Scientific and Technological Development.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ArtesunateNeoplasmsAntineoplastic AgentsHumansAnimalsDrug Resistance, NeoplasmArtemisinins

Stichwörter der Autor:innen

ArtesunateCancerChemoresistanceChemotherapyDrug delivery

Substanzen

ArtesunateAntineoplastic AgentsArtemisinins

Autor:innen und Institutionen

  • Department of Chemistry and Biochemistry, Mendel University in Brno, Zemedelska 1, Brno CZ-613 00, Czech Republic.
  • Department of Chemistry and Biochemistry, Mendel University in Brno, Zemedelska 1, Brno CZ-613 00, Czech Republic; MendelFOLD s.r.o., Zezulova 174/3, Brno CZ-613 00, Czech Republic.
  • University of Belgrade - Faculty of Chemistry, PO Box 51, Studentski trg 16, Belgrade 11158, Serbia.
  • Therapeutic Innovation Research Center (NUPIT), Federal University of Pernambuco, Recife, PE, Brazil. Electronic address: jamile.taniele@ufpe.br.
  • Department of Chemistry and Biochemistry, Mendel University in Brno, Zemedelska 1, Brno CZ-613 00, Czech Republic. Electronic address: miguel.rodrigo@mendelu.cz.

Förderung

  • Mendel University in Brno
  • National Council for Scientific and Technological Development

Zitieren

APA

Petrlak, F., Jemelikova, V., Hanzlikova, A., Slesingerova, T., Haddad, Y., Opsenica, I., Taniele-Silva, J., & Rodrigo, M. A. M. (2026). Artesunate as an emerging anticancer modality: Insights and advances. Pharmacological Research. https://doi.org/10.1016/j.phrs.2026.108317

Vancouver

Petrlak F, Jemelikova V, Hanzlikova A, Slesingerova T, Haddad Y, Opsenica I, et al. Artesunate as an emerging anticancer modality: Insights and advances. Pharmacological Research. 2026. doi:10.1016/j.phrs.2026.108317

BibTeX
@article{Petrlak2026,
  author = {Petrlak, Frantisek and Jemelikova, Vendula and Hanzlikova, Anna and Slesingerova, Terezie and Haddad, Yazan and Opsenica, Igor and Taniele-Silva, Jamile and Rodrigo, Miguel Angel Merlos},
  title = {Artesunate as an emerging anticancer modality: Insights and advances},
  journal = {Pharmacological Research},
  year = {2026},
  doi = {10.1016/j.phrs.2026.108317}
}
Kostenlos starten →